Resistencia antibiótica de Escherichia coli y Staphylococcus saprophyticus en la infección urinaria de un hospital público

Jarvis Raraz-Vidal, Henry Allpas-Gomez, Omar Raraz-Vidal

Resumen


Métodos:Estudio descriptivo, retrospectivo de corte transversal.Se realizóen el servicio de Medicina Interna del Hospital Municipal los Olivos (HMLO).Participantes: historia clínica de pacientes hospitalizados con infección urinaria en el servicio de Medicina Interna.Intervenciones: Según los criterios de inclusión y exclusión se obtuvieron,96 historias clínicas (HC) del año 2013. Se utilizó un instrumento de recolección validado.Se realizó el análisis descriptivo con software estadístico STATA versión 25. Resultados:De las 96 HC, la edad promedio fue 55,04 años, los agentes microbianos más frecuentes fueron: la Escherichia coli con 85,3%, Staphylococcus saprophyticus 4.2% y Klebsiella pneumoniae 3,1%. La prevalencia de productores de betalactamasa espectro extendido (BLEE) fue 10,4%. Los antibióticos más resistentes fueron: trimetoprim/sulfametoxazol 89,6%, ampicilina 86%, piperacilina 84,6%, tetraciclina 79,2% y ciprofloxacino 70,8%. Los antibióticos más sensibles fueron: amikacina 100%, imipenem 100%, ertapenem 98%, meropenem 96% y piperacilina/tazobactam 96%.  Conclusión: El uropatógeno más frecuente en pacientes con ITU hospitalizados fue la E. coli. Los antibióticos que presentaron resistencia a la E. coli fueron: trimetoprim/sulfametoxazol, ampicilina, piperacilina, tetraciclina y ciprofloxacino, y para el S. Saprophyticus fueron: amoxicilina/ ácido clavulánico, trimetoprim/sulfametoxazol, ceftriaxona y ciprofloxacino

Palabras clave


Infección urinaria, resistencia, antibióticos, Escherichia coli, Staphylococcus aprophyticus.

Texto completo:

PDF

Referencias


Arana, D. M., Rubio, M., & Alós, J.-I. (2017). Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003-2014). Enfermedades Infecciosas Y Microbiologia Clinica, 35(5), 293-298. https://doi.org/10.1016/j.eimc.2016.02.018.

Asadi Karam, M. R., Habibi, M., & Bouzari, S. (2019). Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Molecular Immunology, 108, 56-67. https://doi.org/10.1016/j.molimm.2019.02.007.

Barker, A. K., Brown, K., Ahsan, M., Sengupta, S., & Safdar, N. (2017). Social determinants of antibiotic misuse: A qualitative study of community members in Haryana, India. BMC Public Health, 17(1), 333. https://doi.org/10.1186/s12889-017-4261-4.

Bonkat, G., Bartoletti, R., Bruyère, F., Cai, T., & Geerlings, S. (2019). EAU Guidelines on Urological infections 2019. Disponible en: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urological-infections-2019.pdf. (Acceso septiembre 2021).

Caron, F., Wehrle, V., & Etienne, M. (2017). The comeback of trimethoprim in France. Medecine Et Maladies Infectieuses, 47(4), 253-260. https://doi.org/10.1016/j.medmal.2016.12.001.

Chervet, D., Lortholary, O., Zahar, J.-R., Dufougeray, A., Pilmis, B., & Partouche, H. (2018). Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015. Medecine Et Maladies Infectieuses, 48(3), 188-192. https://doi.org/10.1016/j.medmal.2017.09.013.

Dautt-Leyva, J. G., Canizalez-Román, A., Acosta Alfaro, L. F., Gonzalez-Ibarra, F., & Murillo-Llanes, J. (2018). Maternal and perinatal complications in pregnant women with urinary tract infection caused by Escherichia coli. The Journal of Obstetrics and Gynaecology Research, 44(8), 1384-1390. https://doi.org/10.1111/jog.13687.

Ehlers, S., & Merrill, S. A. (2021). Staphylococcus Saprophyticus. En StatPearls. StatPearls Publishing. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK482367/. (Acceso septiembre 2021).

Eriksson, A., Giske, C. G., & Ternhag, A. (2013). The relative importance of Staphylococcus saprophyticus as a urinary tract pathogen: Distribution of bacteria among urinary samples analysed during 1 year at a major Swedish laboratory. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 121(1), 72-78. https://doi.org/10.1111/j.1600-0463.2012.02937.x.

Fatima, S., Muhammad, I. N., Usman, S., Jamil, S., Khan, M. N., & Khan, S. I. (2018). Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients. Indian Journal of Pharmacology, 50(2), 69-74. https://doi.org/10.4103/ijp.IJP_200_17.

Gonzales, E., Patiño, L., Ore, E., Martínez, V., Moreno, S., Cruzado, N. B., Rojas, R., Quispe, M. del C., Carbonell, I., Villarreal, F., Maza, G., Olivo, J., Vicuata, R., & Bustamante, D. (2019). β-lactamasas de espectro extendido tipo CTX-M en aislamientos clínicos de Escherichia coli y Klebsiella pneumoniae en el Instituto Nacional de Salud del Niño-Breña, Lima, Perú. Revista Medica Herediana, 30(4), 242-248. https://doi.org/10.20453/rmh.v30i4.3659.

Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., Soper, D. E., Infectious Diseases Society of America, & European Society for Microbiology and Infectious Diseases. (2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 52(5), e103-120. https://doi.org/10.1093/cid/ciq257.

Hashemzadeh, M., Dezfuli, A. A. Z., Nashibi, R., Jahangirimehr, F., & Akbarian, Z. A. (2021). Study of biofilm formation, structure and antibiotic resistance in Staphylococcus saprophyticus strains causing urinary tract infection in women in Ahvaz, Iran. New Microbes and New Infections, 39, 100831. https://doi.org/10.1016/j.nmni.2020.100831.

Huang, Y., Zeng, L., Doi, Y., Lv, L., & Liu, J.-H. (2020). Extended-spectrum β-lactamase-producing Escherichia coli. The Lancet. Infectious Diseases, 20(4), 404-405. https://doi.org/10.1016/S1473-3099(20)30115-8.

Isberg, H. K., Hedin, K., Melander, E., Mölstad, S., & Beckman, A. (2019). Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study. PLOS ONE, 14(3), e0214572. https://doi.org/10.1371/journal.pone.0214572.

Jhora, S. T., & Paul, S. (2011). Urinary Tract Infections Caused by Staphylococcus saprophyticus and their antimicrobial sensitivity pattern in Young Adult Women. Bangladesh Journal of Medical Microbiology, 5(1), 21-25. https://doi.org/10.3329/bjmm.v5i1.15817.

Khoshbakht, R., Salimi, A., Shirzad Aski, H., & Keshavarzi, H. (2012). Antibiotic Susceptibility of Bacterial Strains Isolated From Urinary Tract Infections in Karaj, Iran. Jundishapur Journal of Microbiology, 6(1), 86-90. https://doi.org/10.5812/jjm.4830.

Kim, J. H., Sun, H. Y., Kim, T. H., Shim, S. R., Doo, S. W., Yang, W. J., Lee, E. J., & Song, Y. S. (2016). Prevalence of antibiotic susceptibility and resistance of Escherichia coli in acute uncomplicated cystitis in Korea: Systematic review and meta-analysis. Medicine, 95(36), e4663. https://doi.org/10.1097/MD.0000000000004663.

Kranz, J., Schmidt, S., Lebert, C., Schneidewind, L., Mandraka, F., Kunze, M., Helbig, S., Vahlensieck, W., Naber, K., Schmiemann, G., & Wagenlehner, F. M. (2018). The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention. Urologia Internationalis, 100(3), 271-278. https://doi.org/10.1159/000487645.

Kuroda, M., Yamashita, A., Hirakawa, H., Kumano, M., Morikawa, K., Higashide, M., Maruyama, A., Inose, Y., Matoba, K., Toh, H., Kuhara, S., Hattori, M., & Ohta, T. (2005). Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection. Proceedings of the National Academy of Sciences of the United States of America, 102(37), 13272-13277. https://doi.org/10.1073/pnas.0502950102.

Landers, T. F., Cohen, B., Wittum, T. E., & Larson, E. L. (2012). A review of antibiotic use in food animals: perspective, policy, and potential. Public health reports (Washington, D.C.: 1974), 127(1), 4–22. https://doi.org/10.1177/003335491212700103

Lee, D. S., Lee, S.-J., & Choe, H.-S. (2018). Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance. BioMed Research International, 2018, 7656752. https://doi.org/10.1155/2018/7656752.

Lüthje, P., & Brauner, A. (2014). Virulence factors of uropathogenic E. coli and their interaction with the host. Advances in Microbial Physiology, 65, 337-372. https://doi.org/10.1016/bs.ampbs.2014.08.006.

Málaga, G. (2014). Las enfermedades crónicas no transmisibles, un reto por enfrentar. Revista Peruana de Medicina Experimental y Salud Publica, 31(1), 06-08. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342014000100001&lng=es&tlng=es. (Acceso septiembre 2021).

Mazumder, R., Abdullah, A., Ahmed, D., & Hussain, A. (2020). High Prevalence of blaCTX-M-15 Gene among Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates Causing Extraintestinal Infections in Bangladesh. Antibiotics (Basel, Switzerland), 9(11), E796. https://doi.org/10.3390/antibiotics9110796.

Mortazavi-Tabatabaei, S. A. R., Ghaderkhani, J., Nazari, A., Sayehmiri, K., Sayehmiri, F., & Pakzad, I. (2019). Pattern of Antibacterial Resistance in Urinary Tract Infections: A Systematic Review and Meta-analysis. International Journal of Preventive Medicine, 10. https://doi.org/10.4103/ijpvm.IJPVM_419_17.

Orden, B., Martínez-Ruiz, R., & Millán-Pérez, R. (2008). ¿Qué estamos aprendiendo de Staphylococcus saprophyticus? Enfermedades Infecciosas y Microbiología Clínica, 26(8), 495-499. Disponible en: https://medes.com/publication/44188. (Acceso septiembre 2021).

Pailhoriès, H., Cassisa, V., Chenouard, R., Kempf, M., Eveillard, M., & Lemarié, C. (2017). Staphylococcus saprophyticus: Which beta-lactam? International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 65, 63-66. https://doi.org/10.1016/j.ijid.2017.10.001.

Peirano, G., & Pitout, J. D. D. (2019). Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options. Drugs, 79(14), 1529-1541. https://doi.org/10.1007/s40265-019-01180-3.

Pérez, N., Pavas, N., & Rodríguez, E. I. (2011). Resistencia a los antibióticos en Escherichia coli con beta-lactamasas de espectro extendido en un hospital de la Orinoquia colombiana. Infectio, 15(3), 147-154. https://doi.org/10.1016/S0123-9392(11)70078-9.

Pormohammad, A., Nasiri, M. J., & Azimi, T. (2019). Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: A systematic review and meta-analysis. Infection and Drug Resistance, 12, 1181-1197. https://doi.org/10.2147/IDR.S201324.

Sanchez, G. V., Adams, S. J. E., Baird, A. M. G., Master, R. N., Clark, R. B., & Bordon, J. M. (2013). Escherichia coli antimicrobial resistance increased faster among geriatric outpatients compared with adult outpatients in the USA, 2000-10. The Journal of Antimicrobial Chemotherapy, 68(8), 1838-1841. https://doi.org/10.1093/jac/dkt110.

Sanyal, C., Husereau, D. R., Beahm, N. P., Smyth, D., & Tsuyuki, R. T. (2019). Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists. BMC Health Services Research, 19(1), 499. https://doi.org/10.1186/s12913-019-4303-y.

Schito, G. C., Naber, K. G., Botto, H., Palou, J., Mazzei, T., Gualco, L., & Marchese, A. (2009). The ARESC study: An international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. International Journal of Antimicrobial Agents, 34(5), 407-413. https://doi.org/10.1016/j.ijantimicag.2009.04.012.

Seitz, M., Stief, C., & Waidelich, R. (2017). Local epidemiology and resistance profiles in acute uncomplicated cystitis (AUC) in women: A prospective cohort study in an urban urological ambulatory setting. BMC Infectious Diseases, 17(1), 685. https://doi.org/10.1186/s12879-017-2789-7.

Sousa, V. S., Rabello, R. F., Dias, R. C., Martins, I. S., Santos, L. B., Alves, E. M., Riley, L. W., & Moreira, B. M. (2013). Time-based distribution of Staphylococcus saprophyticus pulsed field gel-electrophoresis clusters in community-acquired urinary tract infections. Memorias do Instituto Oswaldo Cruz, 108(1), 73–76. https://doi.org/10.1590/s0074-02762013000100012.

Touati, A., & Mairi, A. (2021). Plasmid-Determined Colistin Resistance in the North African Countries: A Systematic Review. Microbial Drug Resistance, 27(1), 121-133. https://doi.org/10.1089/mdr.2019.0471.

Treviño, M., Losada, I., Fernández-Pérez, B., Coira, A., Peña-Rodríguez, M. F., Hervada, X., & Study Group SOGAMIC for the study of resistance in Galicia. (2016). [Surveillance of antimicrobial susceptibility of Escherichia coli producing urinary tract infections in Galicia (Spain)]. Revista Espanola De Quimioterapia: Publicacion Oficial De La Sociedad Espanola De Quimioterapia, 29(2), 86-90. Disponible en: https://seq.es/seq/0214-3429/29/2/trevino11mar2016.pdf. (Acceso septiembre 2021).

ur Rahman, S., Ali, T., Ali, I., Khan, N. A., Han, B., & Gao, J. (2018). The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases. BioMed Research International, 2018, e9519718. https://doi.org/10.1155/2018/9519718.

Vásquez, V., Ampuero, D., & Padilla, B. (2017). Urinary tract infections in inpatients: That challenge. Revista Espanola De Quimioterapia: Publicacion Oficial De La Sociedad Espanola De Quimioterapia, 30 Suppl 1, 39-41. Disponible en: https://seq.es/seq/0214-3429/30/suppl1/08vasquez.pdf. (Acceso septiembre 2021).

Vieira, D. C., Lima, W. G., & de Paiva, M. C. (2020). Plasmid-mediated quinolone resistance (PMQR) among Enterobacteriales in Latin America: A systematic review. Molecular Biology Reports, 47(2), 1471-1483. https://doi.org/10.1007/s11033-019-05220-9.

Wistrand-Yuen, E., Knopp, M., Hjort, K., Koskiniemi, S., Berg, O. G., & Andersson, D. I. (2018). Evolution of high-level resistance during low-level antibiotic exposure. Nature Communications, 9(1), 1599. https://doi.org/10.1038/s41467-018-04059-1.

Yang, B., Yang, F., Wang, S., Wang, Q., Liu, Z., Feng, W., Sun, F., & Xia, P. (2018). Analysis of the spectrum and antibiotic resistance of uropathogens in outpatients at a tertiary hospital. Journal of Chemotherapy (Florence, Italy), 30(3), 145-149. https://doi.org/10.1080/1120009X.2017.1418646.

Yılmaz, N., Ağuş, N., Bayram, A., Şamlıoğlu, P., Şirin, M. C., Derici, Y. K., & Hancı, S. Y. (2016). Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turkish Journal of Urology, 42(1), 32-36. https://doi.org/10.5152/tud.2016.90836.

Zwane, T., Shuping, L., & Perovic, O. (2021). Etiology and Antimicrobial Susceptibility of Pathogens Associated with Urinary Tract Infections among Women Attending Antenatal Care in Four South African Tertiary-Level Facilities, 2015–2019. Antibiotics, 10(6), 669. https://doi.org/10.3390/antibiotics10060669.


Enlaces refback

  • No hay ningún enlace refback.


Bookmark and Share


Copyright (c) 2022 Boletín de Malariología y Salud Ambiental